Maagda, Cheryl .

HRN: 24-89-02  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/22/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/22/2024
04/29/2024
IV
1.5 G
Q8
Breast Abacess
Waiting Final Action 
04/22/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/22/2024
04/29/2024
IV
600
Q8
Breast Abscess
Waiting Final Action 
04/23/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/23/2024
04/29/2024
IV
4.5gm
Q8
Septicemia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: